
1. Front Immunol. 2021 Oct 1;12:763313. doi: 10.3389/fimmu.2021.763313. eCollection 
2021.

Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven
Immune-Epigenetic Programming by SARS-Cov-2.

Roy RK(1), Sharma U(2), Wasson MK(1), Jain A(2), Hassan MI(3), Prakash H(1).

Author information: 
(1)Amity Institute of Virology and Immunology, Amity University, NOIDA, Udham
Singh Nagar, India.
(2)Department of Zoology, Central University of Punjab, Bathinda, India.
(3)Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia,
Jamia Nagar, New Delhi, India.

DOI: 10.3389/fimmu.2021.763313 
PMCID: PMC8519338
PMID: 34659270  [Indexed for MEDLINE]

Conflict of interest statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could 
be construed as a potential conflict of interest.

